Adults 10 to 19, any sex, with Chronic Pancreatitis or Acute Recurrent Pancreatitis. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
The Abdominal Pain Index (API) assesses characteristics of abdominal pain during the previous 2 weeks including the number of days with pain, number of pain episodes per day, typical pain episode duration, and typical pain intensity. An index is computed with higher scores indicating greater abdominal pain severity. A mean score is reported on a scale of 0 to 4, where higher values indicate more severe (worse) abdominal pain severity.
T1 (Baseline)
Group
Value
95% CI
Pain Education (WebED)
2.11
± 1.06
Web-based CBT (WebMAP)
1.74
± 1.61
T2 (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
1.99
± 1.22
Web-based CBT (WebMAP)
1.61
± 1.19
T3 (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
1.62
± 1.27
Web-based CBT (WebMAP)
1.48
± 1.19
Change in Pain-related DisabilitySecondary· Baseline, 12 weeks, 6 months
The Child Activity Limitations Interview (CALI-9) is a daily diary validated to assess perceived difficulty in completing 9 daily activities as a measure of pain-related disability. Responses are rated on a 5-point scale (0-4) with higher scores indicating greater perceived difficulty with activities. Youth will provide ratings daily for 7 days on their online diaries at each assessment period. Mean total activity limitations across the reporting period is used in analyses, with higher scores indicating greater disability. The maximum possible total score is 36.
T1 (Baseline)
Group
Value
95% CI
Pain Education (WebED)
22.03
± 7.11
Web-based CBT (WebMAP)
20.47
± 6.18
T2 (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
22.09
± 9.96
Web-based CBT (WebMAP)
18.95
± 5.59
T3 (6-month Follow-up)
Group
Value
95% CI
Pain Education (WebED)
24.24
± 8.57
Web-based CBT (WebMAP)
16.48
± 6.72
Change in Health-related Quality of LifeSecondary· Baseline, 12 weeks, 6 months
The Pediatric Quality of Life Inventory (Peds-QL) assesses several domains of functioning, including physical, social, emotional, and academic functioning. The PedsQL is widely used as it demonstrates good reliability for both the parent and child self-report measures. Higher scores indicate fewer difficulties (better) health-related quality of life. Sub scales of physical and psychosocial health will be used in analyses. All scales range from 0 to 100.
T1 Physical Health (Baseline)
Group
Value
95% CI
Pain Education (WebED)
59.59
± 23.81
Web-based CBT (WebMAP)
60.73
± 24.57
T2 Physical Health (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
62.27
± 25.22
Web-based CBT (WebMAP)
64.03
± 24.38
T3 Physical Health (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
64.10
± 27.31
Web-based CBT (WebMAP)
64.81
± 22.38
T1 Psychosocial Health (Baseline)
Group
Value
95% CI
Pain Education (WebED)
62.27
± 15.33
Web-based CBT (WebMAP)
62.2
± 21.06
T2 Psychosocial Health (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
66.06
± 19.94
Web-based CBT (WebMAP)
65.58
± 20.71
T3 Psychosocial Health (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
70.69
± 17.95
Web-based CBT (WebMAP)
64.99
± 18.37
Change in Emotional DistressSecondary· Baseline, 12 weeks, 6 months
The Patient-Reported Outcomes Measurement Information System (PROMIS) Pediatric Emotional Distress Scales include an 8-item scale of anxiety (Pediatric v2.0 SF8a Anxiety) that assesses fear (e.g., fearfulness), anxious misery (e.g., worry) and hyperarousal (e.g., nervousness) and 8-item scale of depressive symptoms (Pediatric v2.0 SF8a Depressive Symptoms) that evaluates negative mood, view of self and social cognitions. Raw scores and T-scores are computed with T-scores above 60 indicating clinically elevated (worse) symptoms. The general population mean T-score is 50, with a standard deviati
T1 Depression (Baseline)
Group
Value
95% CI
Pain Education (WebED)
50.97
± 9.78
Web-based CBT (WebMAP)
50.53
± 11.48
T2 Depression (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
51.22
± 10.54
Web-based CBT (WebMAP)
50.20
± 13.11
T3 Depression (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
50.04
± 10.69
Web-based CBT (WebMAP)
51.10
± 12.12
T1 Anxiety (Baseline)
Group
Value
95% CI
Pain Education (WebED)
51.07
± 10.44
Web-based CBT (WebMAP)
10.19
± 10.06
T2 Anxiety (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
51.06
± 12.38
Web-based CBT (WebMAP)
48.68
± 11.56
T3 Anxiety (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
48.95
± 10.19
Web-based CBT (WebMAP)
50.26
± 11.12
Change in Opioid UseSecondary· Baseline, 6 months
Over the counter and prescription (opioid and non-opioid) medication use in the preceding 7 days.
T1 (Baseline)
Group
Value
95% CI
Pain Education (WebED)
9
Web-based CBT (WebMAP)
6
Pain Education (WebED)
35
Web-based CBT (WebMAP)
40
T3 (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
7
Web-based CBT (WebMAP)
4
Pain Education (WebED)
37
Web-based CBT (WebMAP)
40
Change in Pain Self-efficacySecondary· Baseline, 12 weeks, 6 months
The Pain Self-Efficacy Scale is a 7-item measure that assesses the child's beliefs in carrying out activities when in pain. The scale has demonstrated good internal consistency, cross-informant reliability with parent report, and strong construct validity. Higher scores (score range 7-35) indicate higher self-efficacy.
T1 (Baseline)
Group
Value
95% CI
Pain Education (WebED)
21.76
± 6.19
Web-based CBT (WebMAP)
22.72
± 6.07
T2 (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
19.78
± 6.85
Web-based CBT (WebMAP)
21.11
± 7.06
T3 (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
20.37
± 8
Web-based CBT (WebMAP)
20.3
± 5.64
Change in Parent Impact of PainSecondary· Baseline, 12 weeks, 6 months
Parents will complete the Bath Adolescent Pain Questionnaire-Parent Impact Questionnaire (BAPQ-PIQ), a measure of the impact of parenting an adolescent with chronic pain. The BAPQ-PIQ is a 62-item questionnaire with 8 scales including: depressive symptoms, anxiety, pain catastrophizing, self-blame, partner relationship, social (leisure) functioning, parental behavior, and parental role strain. Items are rated on a 5-point frequency response scale (0 = never, 4 = always) with higher scores indicating more impaired (worse) functioning for all subscales. The BAPQ-PIQ has demonstrated good reliabi
T1 Depression (Baseline)
Group
Value
95% CI
Pain Education (WebED)
13.67
± 6.17
Web-based CBT (WebMAP)
13.57
± 5.84
T2 Depression (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
13.31
± 6.13
Web-based CBT (WebMAP)
12.01
± 6.73
T3 Depression (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
12.21
± 5.28
Web-based CBT (WebMAP)
12.37
± 6.48
T1 Anxiety (Baseline)
Group
Value
95% CI
Pain Education (WebED)
11.60
± 5.03
Web-based CBT (WebMAP)
10.31
± 5.70
T2 Anxiety (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
10.19
± 4.75
Web-based CBT (WebMAP)
9.12
± 6.17
T3 Anxiety (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
9.28
± 5.14
Web-based CBT (WebMAP)
9.81
± 5.75
Change in Pain InterferenceSecondary· Baseline, 12 weeks, 6 months
The PROMIS Pain Interference - v2.0 Pediatric Short Form 8a includes 8 items to assess consequences of pain on relevant aspects of one's life. This includes the extent to which pain hinders engagement with social, cognitive, emotional, physical, and recreational activities. The scale has been validated in pediatric patients with chronic pain. Raw scores and T-scores are computed with T-scores above 60 indicating clinically elevated (worse) symptoms. T-scores range from 34-78. The general population mean T-score is 50, with a standard deviation of 10.
T1 (Baseline)
Group
Value
95% CI
Pain Education (WebED)
56.44
± 11.17
Web-based CBT (WebMAP)
55.83
± 12.01
T2 (Post-treatment, 12 weeks)
Group
Value
95% CI
Pain Education (WebED)
56.65
± 11.00
Web-based CBT (WebMAP)
53.21
± 13.28
T3 (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
53.3
± 12.84
Web-based CBT (WebMAP)
55.69
± 10.71
Change in Health Service UtilizationSecondary· Baseline, 6 months
Parents will complete the Client Service Receipt Inventory-Pain version, a measure of service use, out-of-pocket expenses, and lost work time incurred by families for the evaluation or management of the child's chronic pain. Questions pertain to hospital admissions, outpatient services, community services (e.g., tutor, lawyer), medications, lost work time, paid help, and other costs. We will compute the following variables: total number of services used by category, number of lost parental work days, and number of out-of-pocket expenses; visits, medications, other treatments, and indirect cost
T1 Emergency Visits (Baseline)
Group
Value
95% CI
Pain Education (WebED)
1.98
± 1.92
Web-based CBT (WebMAP)
2.73
± 4.05
T3 Emergency Visits (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
1.62
± 1.95
Web-based CBT (WebMAP)
1.72
± 2.15
T1 Outpatient Dr Visits (Baseline)
Group
Value
95% CI
Pain Education (WebED)
4.71
± 3.24
Web-based CBT (WebMAP)
4.27
± 3.01
T3 Outpatient Dr Visits (6-month follow-up)
Group
Value
95% CI
Pain Education (WebED)
4.55
± 3.03
Web-based CBT (WebMAP)
4.35
± 3.69
Sponsor's own description
Abdominal pain is common in children with chronic and acute recurring pancreatitis (CP, ARP), and as they continue into adulthood, the disease progresses with increased pain and greater exposure to opioids. Despite the relevancy of early pain self-management for childhood pancreatitis, there have been no studies of non-pharmacological pain intervention in this population. The proposed project will evaluate a web-based cognitive behavioral pain management program delivered to a cohort of well-phenotyped children with CP/ARP and some community participants to reduce pain, pain-related disability and enhance HRQOL; it will also identify genetic risk factors and clinical and behavioral phenotypic factors associated with treatment response to enable precision medicine approaches.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases
· recruiting
NCT06655051 — Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancr
· NA
· recruiting
NCT06937294 — Metformin in Post Chronic Pancreatitis Diabetes Mellitus
· Phase 4
· recruiting
NCT07109180 — Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOT
· NA
· recruiting
NCT06925204 — Natural Course and Therapeutic Effect of Chronic Pancreatitis
· recruiting
Other Seattle Children's Hospital trials
Trials by the same sponsor.
NCT07522112 — Evaluating a Shared Decision-making Intervention for Families About Firearm Storage
· NA
· not yet recruiting
NCT06864611 — Evaluating Huddles as a Novel Approach to Improving Concussion Safety
· NA
· not yet recruiting
NCT07424157 — Long-Term Follow-Up of Subjects Treated With Seattle Children's Therapeutics Gene Therapy Products
· not yet recruiting
NCT07148050 — Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimer
· Phase 1
· recruiting
NCT07097792 — Concussion Recovery and Support Program
· NA
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seattle Children's Hospital
Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03707431.